0001209191-17-064274.txt : 20171206
0001209191-17-064274.hdr.sgml : 20171206
20171206194316
ACCESSION NUMBER: 0001209191-17-064274
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171204
FILED AS OF DATE: 20171206
DATE AS OF CHANGE: 20171206
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BALTIMORE DAVID
CENTRAL INDEX KEY: 0001185858
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35670
FILM NUMBER: 171243268
MAIL ADDRESS:
STREET 1: AMGEN INC.
STREET 2: ONE AMGEN CENTER DRIVE
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320-1799
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Regulus Therapeutics Inc.
CENTRAL INDEX KEY: 0001505512
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 264738379
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10614 SCIENCE CENTER DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-202-6300
MAIL ADDRESS:
STREET 1: 10614 SCIENCE CENTER DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-12-04
0
0001505512
Regulus Therapeutics Inc.
RGLS
0001185858
BALTIMORE DAVID
C/O REGULUS THERAPEUTICS INC.
10614 SCIENCE CENTER DRIVE
SAN DIEGO
CA
92121
1
0
0
0
Common Stock
2017-12-04
4
A
0
60674
0.89
A
60674
D
Restricted Stock Units (RSU) issued in lieu of 2018 annual retainer and meeting fees of $54,000. The RSUs vest ratably on a quarterly basis on the last day of each calendar quarter in 2018, subject to the reporting person's continuous service to Regulus.
Christopher Aker, Attorney in Fact
2017-12-06